Daisy Health Care Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-07-2024
- Paid Up Capital ₹ 2.50 M
as on 16-07-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.26 M
as on 16-07-2024
- Revenue 74.55%
(FY 2022)
- Profit 346.02%
(FY 2022)
- Ebitda 62.91%
(FY 2022)
- Net Worth 37.29%
(FY 2022)
- Total Assets 6.13%
(FY 2022)
About Daisy Health Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.26 M.
Saravanan Ramachandran and Daisy Thangaiah serve as directors at the Company.
- CIN/LLPIN
U85100TZ2009PTC015543
- Company No.
015543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Tirupur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Daisy Health Care Private Limited offer?
Daisy Health Care Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Skin Treatment Solution, Dermatology Treatment Services.
Who are the key members and board of directors at Daisy Health Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saravanan Ramachandran  | Director | 20-Oct-2009 | Current |
| Daisy Thangaiah | Director | 20-Oct-2009 | Current |
Financial Performance of Daisy Health Care.
Daisy Health Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.55% increase. The company also saw a substantial improvement in profitability, with a 346.02% increase in profit. The company's net worth Soared by an impressive increase of 37.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daisy Health Care?
In 2022, Daisy Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Herbal Galanicals LlpActive 10 years 3 monthsSaravanan Ramachandran and Daisy Thangaiah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 15 Jul 2015 | ₹1.26 M | Open |
How Many Employees Work at Daisy Health Care?
Unlock and access historical data on people associated with Daisy Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daisy Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daisy Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
